ArticleiScience2023

Cancer vaccines based on whole-tumor lysate or neoepitopes with validated HLA binding outperform those with predicted HLA-binding affinity.

Hajer Fritah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.